Biotech

All Articles

Turnstone gives up 60%, agitates C-suite to extend cash

.Turnstone Biologics is minimizing its head count through 60% and also shocking its C-suite if you w...

Gilead gives up on $15M MASH wager after weighing preclinical information

.In a year that has actually seen a permission and a raft of readouts for metabolic dysfunction-asso...

Texas biotech centers cancer cells deal, pins wishes on weight problems

.Alaunos Rehabs is actually axing a contract with Precigen, giving up licensing legal rights to an i...

Capricor shares extra records for DMD treatment after initiating BLA

.Capricor Rehabs is actually taking a victory lap for their phase 2 Duchenne muscle dystrophy (DMD) ...

FDA places Kezar lupus trial in hold complying with 4 individual deaths

.The FDA has positioned Kezar Lifestyle Sciences' lupus trial on hold after the biotech hailed 4 fat...

Phase 3 Historian Rock test reaches SMA target, sending stock up 200%

.A phase 3 test of Intellectual Rock's vertebral muscle degeneration (SMA) prospect has actually str...

CAMP 4 is most current to eye IPO, while Upstream point out $182M planning

.RNA biotech CAMP4 Therapeutics has actually marked out prepare for a $67 thousand IPO, along with i...

Galecto purchases leukemia drug, falls bone tissue cancer cells resource in pivot

.A year after the failure of an idiopathic pulmonary fibrosis prospect delivered Galecto on a seek r...

Judo throws down $100M to knock senseless renal health condition

.Taking the floor covering is actually Judo Biography, a promising biotech equipped along with $100 ...

AstraZeneca pays for CSPC $100M for preclinical cardiovascular disease drug

.AstraZeneca has actually paid CSPC Pharmaceutical Group $100 thousand for a preclinical cardiovascu...